feed,title,long_url,short_url
InsiderMonkey,NZS Capitalâ€™s Q4 2023 Investor Letter,https://insidermonkey.com/blog/--1257488,
InsiderMonkey,Multiple Reasons for the Outperformance of Wingstop (WING),https://insidermonkey.com/blog/--1257456,
InsiderMonkey,Strong Pricing and Margin Trends Helped Summit Materials (SUM) in Q4,https://insidermonkey.com/blog/--1257458,
InsiderMonkey,"Cytokinetics, Incorporated (CYTK) Rose on Successful Clinical Trial",https://insidermonkey.com/blog/--1257451,
